GPs warned of surge in demand for Mounjaro from health service following hike by US pharmaceutical firm

Manufacturer Lilly has announced plans to hike the amount it charges private providers in the UK to bring it into line with 'other developed countries'.

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions